Mupirocin is widely used to decolonize patients carrying Staphylococcus aureus, especially methicillin-resistant S. aureus (MRSA). The aim of this study was to determine the presence of high-level mupirocin resistance by a new commercially available mupA genotypic diagnostic product, mupA EVIGENE assay (AdvanDx).
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3020815 | PMC |
| http://dx.doi.org/10.1128/JCM.00088-10 | DOI Listing |
Publication Analysis
Top Keywords
mupa evigene
8
evigene assay
8
high-level mupirocin
8
mupirocin resistance
8
staphylococcus aureus
8
evaluation mupa
4
assay determination
4
determination high-level
4
resistance staphylococcus
4
aureus mupirocin
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!